CN106722965A - 一种用于缓解疲劳的保健品配方 - Google Patents
一种用于缓解疲劳的保健品配方 Download PDFInfo
- Publication number
- CN106722965A CN106722965A CN201710021259.8A CN201710021259A CN106722965A CN 106722965 A CN106722965 A CN 106722965A CN 201710021259 A CN201710021259 A CN 201710021259A CN 106722965 A CN106722965 A CN 106722965A
- Authority
- CN
- China
- Prior art keywords
- content
- mass percent
- saponin
- fatigue
- health caring
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000036541 health Effects 0.000 title claims abstract description 25
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 22
- 229930182490 saponin Natural products 0.000 claims abstract description 22
- 229930182494 ginsenoside Natural products 0.000 claims abstract description 11
- 229940089161 ginsenoside Drugs 0.000 claims abstract description 11
- -1 methane series saponin Chemical class 0.000 claims abstract description 11
- 150000007949 saponins Chemical class 0.000 claims abstract description 11
- 240000007817 Olea europaea Species 0.000 claims abstract description 10
- 239000000463 material Substances 0.000 claims abstract description 9
- TZJALUIVHRYQQB-XFDQAQKOSA-N Icariin Natural products O(C)c1ccc(C2=C(O[C@H]3[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)C(=O)c3c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)c(C/C=C(\C)/C)c3O2)cc1 TZJALUIVHRYQQB-XFDQAQKOSA-N 0.000 claims abstract description 8
- TZJALUIVHRYQQB-XLRXWWTNSA-N icariin Chemical compound C1=CC(OC)=CC=C1C1=C(O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)C(=O)C2=C(O)C=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-XLRXWWTNSA-N 0.000 claims abstract description 8
- TZJALUIVHRYQQB-UHFFFAOYSA-N icariine Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(C)O2)O)C(=O)C2=C(O)C=C(OC3C(C(O)C(O)C(CO)O3)O)C(CC=C(C)C)=C2O1 TZJALUIVHRYQQB-UHFFFAOYSA-N 0.000 claims abstract description 8
- 238000000034 method Methods 0.000 claims abstract description 8
- 238000001914 filtration Methods 0.000 claims abstract description 7
- 239000008188 pellet Substances 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 229920002472 Starch Polymers 0.000 claims description 6
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 6
- 235000019698 starch Nutrition 0.000 claims description 6
- 239000008107 starch Substances 0.000 claims description 6
- 239000006188 syrup Substances 0.000 claims description 6
- 235000020357 syrup Nutrition 0.000 claims description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 229930182470 glycoside Natural products 0.000 claims description 4
- 150000002338 glycosides Chemical class 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 2
- 241001494479 Pecora Species 0.000 claims 1
- 240000000111 Saccharum officinarum Species 0.000 claims 1
- 235000007201 Saccharum officinarum Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 7
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 206010016256 fatigue Diseases 0.000 description 15
- 229960004793 sucrose Drugs 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 3
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000018905 epimedium Nutrition 0.000 description 2
- KWTSXDURSIMDCE-QMMMGPOBSA-N (S)-amphetamine Chemical compound C[C@H](N)CC1=CC=CC=C1 KWTSXDURSIMDCE-QMMMGPOBSA-N 0.000 description 1
- YFGHCGITMMYXAQ-UHFFFAOYSA-N 2-[(diphenylmethyl)sulfinyl]acetamide Chemical compound C=1C=CC=CC=1C(S(=O)CC(=O)N)C1=CC=CC=C1 YFGHCGITMMYXAQ-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000424773 Epimedium alpinum Species 0.000 description 1
- 241001016310 Epimedium grandiflorum Species 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 229940025084 amphetamine Drugs 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000009931 harmful effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 229960001165 modafinil Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000000955 neuroendocrine Effects 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种用于缓解疲劳的保健品配方,包括皂苷和、玛咖酰胺和辅助材料,所述的总皂苷含量的质量百分比为1.2;所述的玛咖酰胺含量的质量百分比为0.1;其余为辅助材料。所述的总皂苷包括齐墩果烷系皂苷、淫羊藿苷和人参皂苷;所述的齐墩果烷系皂苷含量为的质量百分比为0.3;所述的淫羊藿苷含量的质量百分比为0.5;所述的人参皂苷含量的质量百分比为0.3;所述的总皂苷还包括其他皂苷。所述的玛咖酰胺由安哥拉树皮采用纯物理提取技术纳料球过滤制得。本发明所涉及的用于缓解疲劳的保健品配方,所采用的有效成分均来自于天然植物,无毒副作用,且没有依赖性。使得缓解疲劳保健品配方的效果得到完善,适用于绝大多数人群。
Description
技术领域
本发明涉及保健品领域,尤其是一种用于缓解疲劳的保健品配方。
背景技术
疲劳性亚健康已成为影响公众身体健康的重大隐患,世界卫生组织的一项全球性预测调查显示,75%的人处于亚健康状态。中国成年人疲劳性亚健康大约为30%。疲劳作为一种生理现象,是指“机体生理过程不能持续其机能在某一特定的水平和/或不能维持预定的运动强度”。疲劳发生后如果得不到及时消除,将会逐渐积累,最终导致机体的神经内分泌及免疫系统调节失常,甚至出现器质性病变,成为破坏人类身心健康的重要因素。
目前,市售的抗疲劳的化学药物如苯丙胺类、莫达非尼、咖啡因等在延缓疲劳发生和消除疲劳方面有较好的效果,但是出现了许多不良反应,如心血管的不良影响、干扰睡眠、精神紊乱、成瘾性等。因此,亟需开发一种安全、有效、无毒副作用的保健品来缓解疲劳,以满足人们的实际需求。
发明内容
本发明的目的是提供一种用于缓解疲劳的保健品配方,能够使缓解疲劳保健品效果更完善,适应绝大多数人群。
为解决上述技术问题,本发明的目的是这样实现的:本发明所涉及的一种用于缓解疲劳的保健品配方,包括皂苷、玛咖酰胺和辅助材料,所述的总皂苷含量的质量百分比为1.2;所述的玛咖酰胺含量的质量百分比为0.1。所述的总皂苷包括齐墩果烷系皂苷、淫羊藿苷和人参皂苷;所述的齐墩果烷系皂苷含量为的质量百分比为0.3;所述的淫羊藿苷含量的质量百分比为0.5;所述的人参皂苷含量的质量百分比为0.3;所述的总皂苷还包括其他皂苷。所述的辅助材料包括淀粉、蔗糖粉、滑石粉、糖浆和75%乙醇;所述的淀粉含量的质量百分比为63%;所述的蔗糖粉含量的质量百分比为33%;所述的滑石粉含量的质量百分比为1%;所述的糖浆含量在每100克保健品中为1ml;其余为75%乙醇。
在上述方案的基础上并作为上述方案的优选方案:
作为优选,所述的齐墩果烷系皂苷、淫羊藿苷和人参皂苷由植物体内合成,采用纯物理提取技术纳料球过滤制得。
作为优选,所述的玛咖酰胺由安哥拉树皮采用纯物理提取技术纳料球过滤制得。
本发明的有益效果是:本发明所涉及的用于缓解疲劳的保健品配方,所采用的有效成分均来自于天然植物,无毒副作用,且没有依赖性。使得缓解疲劳保健品配方的效果得到完善,适用于绝大多数人群。
具体实施方式
下面结合具体实施例对本发明进一步说明。
实施例:本实施例所涉及的用于缓解疲劳的保健品配方,包括皂苷、玛咖酰胺和辅助材料,总皂苷含量的质量百分比为1.2;玛咖酰胺含量的质量百分比为0.1。总皂苷包括齐墩果烷系皂苷、淫羊藿苷和人参皂苷;齐墩果烷系皂苷含量为的质量百分比为0.3;淫羊藿苷含量的质量百分比为0.5;人参皂苷含量的质量百分比为0.3;总皂苷还包括其他皂苷。辅助材料包括淀粉、蔗糖粉、滑石粉、糖浆和75%乙醇;淀粉含量的质量百分比为63%;蔗糖粉含量的质量百分比为33%;滑石粉含量的质量百分比为1%;糖浆含量在每100克保健品中为1ml;其余为75%乙醇。
齐墩果烷系皂苷、淫羊藿苷和人参皂苷由植物体内合成,采用纯物理提取技术纳料球过滤制得。所述的玛咖酰胺由安哥拉树皮采用纯物理提取技术纳料球过滤制得。
以上详细描述了本发明的较佳具体实施例。应当理解,本领域的普通技术人员无需创造性劳动就可以根据本发明的构思做出诸多修改和变化。因此,凡本技术领域中技术人员依本发明的构思在现有技术的基础上通过逻辑分析、推理或者有限的实验可以得到的技术方案,皆应在由权利要求书所确定的保护范围内。
Claims (5)
1.一种用于缓解疲劳的保健品配方,包括皂苷、玛咖酰胺和辅助材料,其特征在于:所述的总皂苷含量的质量百分比为1.2%;所述的玛咖酰胺含量的质量百分比为0.1%;其余为辅助材料。
2.根据权利要求1所述的用于缓解疲劳的保健品配方,其特征在于:所述的总皂苷包括齐墩果烷系皂苷、淫羊藿苷和人参皂苷;所述的齐墩果烷系皂苷含量为的质量百分比为0.3%;所述的淫羊藿苷含量的质量百分比为0.5%;所述的人参皂苷含量的质量百分比为0.3%;所述的总皂苷还包括其他皂苷。
3.根据权利要求1所述的用于保健品配方,其特征在于:所述的辅助材料包括淀粉、蔗糖粉、滑石粉、糖浆和75%乙醇;所述的淀粉含量的质量百分比为63%;所述的蔗糖粉含量的质量百分比为33%;所述的滑石粉含量的质量百分比为1%;所述的糖浆在每100克保健品中的含量为1ml;其余为75%乙醇。
4.根据权利要求2所述的用于保健品配方,其特征在于:所述的齐墩果烷系皂苷、淫羊藿苷和人参皂苷由植物体内合成,采用纯物理提取技术纳料球过滤制得。
5.根据权利要求1所述的用于保健品配方,其特征在于:所述的玛咖酰胺由安哥拉树皮采用纯物理提取技术纳料球过滤制得。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710021259.8A CN106722965A (zh) | 2017-01-12 | 2017-01-12 | 一种用于缓解疲劳的保健品配方 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710021259.8A CN106722965A (zh) | 2017-01-12 | 2017-01-12 | 一种用于缓解疲劳的保健品配方 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106722965A true CN106722965A (zh) | 2017-05-31 |
Family
ID=58947833
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710021259.8A Pending CN106722965A (zh) | 2017-01-12 | 2017-01-12 | 一种用于缓解疲劳的保健品配方 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106722965A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169079A (zh) * | 2013-03-04 | 2013-06-26 | 无锡市天赐康生物科技有限公司 | 一种具有抗疲劳、增强免疫力作用的保健食品及其制备方法 |
CN104224885A (zh) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | 一种缓解体力疲劳的中药组合物 |
CN105582038A (zh) * | 2014-10-24 | 2016-05-18 | 熊慧 | 一种含有人参和玛咖成分的组合物 |
CN105595334A (zh) * | 2015-12-29 | 2016-05-25 | 江南大学 | 一种玛咖复合片及其制备方法 |
CN105920074A (zh) * | 2016-05-04 | 2016-09-07 | 武汉华士特工业生物技术开发有限公司 | 一种玛咖提取物及其制备方法和应用 |
-
2017
- 2017-01-12 CN CN201710021259.8A patent/CN106722965A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169079A (zh) * | 2013-03-04 | 2013-06-26 | 无锡市天赐康生物科技有限公司 | 一种具有抗疲劳、增强免疫力作用的保健食品及其制备方法 |
CN104224885A (zh) * | 2014-09-11 | 2014-12-24 | 上海焦点生物技术有限公司 | 一种缓解体力疲劳的中药组合物 |
CN105582038A (zh) * | 2014-10-24 | 2016-05-18 | 熊慧 | 一种含有人参和玛咖成分的组合物 |
CN105595334A (zh) * | 2015-12-29 | 2016-05-25 | 江南大学 | 一种玛咖复合片及其制备方法 |
CN105920074A (zh) * | 2016-05-04 | 2016-09-07 | 武汉华士特工业生物技术开发有限公司 | 一种玛咖提取物及其制备方法和应用 |
Non-Patent Citations (3)
Title |
---|
常景玲: "《天然生物活性物质及其制备技术》", 31 August 2007, 河南科学技术出版社 * |
贾亮亮等: "淫羊藿苷药理作用的研究进展", 《现代生物医学进展》 * |
赵雪飞等: "玛咖化学成分及波谱特征研究进展", 《食品与药品》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106333885B (zh) | 一种植物提取物及眼部精华液 | |
Kim et al. | Physical, chemical, and biological properties of wonder kelp—Laminaria | |
Bagheri et al. | Anticonvulsant effect of Ferula assa-foetida oleo gum resin on chemical and amygdala-kindled rats | |
Thomas et al. | Ethnomedicinal plants used for the treatment of cuts and wounds by Kuruma tribes, Wayanadu districts of Kerala, India | |
Fazeli-Nasab et al. | Evaluation of total phenol and flavonoid content in a wide variety of native and imported plants | |
Kankanamge et al. | Phytochemical and ethno-pharmacological properties of Lasia spinosa (Kohila): A review | |
CN104758404B (zh) | 一种复方三蛇粉组合物及其制备方法 | |
CN104667135B (zh) | 一种药物组合物、保健品及制备方法 | |
Sarfaraz et al. | Anti-nociceptive potential of lyophilized Beta vulgaris L.(Beet root) powder. | |
CN106722965A (zh) | 一种用于缓解疲劳的保健品配方 | |
CN107198170A (zh) | 一种天然树莓复合口服液的制备配方 | |
KR101136576B1 (ko) | 구연산 스테비오사이드 콜라겐 식이 유황을 함유하는 새콤달콤한 소금 조성물의 제조방법 | |
DE202015106158U1 (de) | Knoblauch-Paste | |
DE202005017053U1 (de) | Nährstoffpräparat, insbesondere geeignet für die nutritive Ergänzung bei erhöhter Gelenkbeanspruchung und Gelenkerkrankungen | |
Raju et al. | Kyllinga nemoralis (Hutch & Dalz)(Cyperaceae): ethnobotany, phytochemistry and pharmacology | |
Vahidi et al. | Evaluation of anti-nociceptive and anti-inflammatory activities of Apium graveolens L. roots extract in mice | |
Senevirathne et al. | Marine macro-and microalgae as potential agents for the prevention of asthma: hyperresponsiveness and inflammatory subjects | |
Adewale et al. | Determination of vitamins in five selected West African green leafy vegetables | |
Lohar et al. | Ethno-functional food studies of non-commercial fruits used by Tribals of southern Rajasthan India | |
Agarwal et al. | Anti epileptic activity of ocimum species: A brief review | |
CN104543983A (zh) | 保健食品组合物 | |
Raj et al. | IMMUNITY BOOSTERS AT ALIMENTARY AND PHYSICAL LEVELS IN RELEVANCE TO COVID-19 | |
Singh et al. | Effects of guava fruit intake on cardiometabolic diseases | |
Hamza et al. | Health benefits of Moringa oleifera: Used as an anti-diabetic agent | |
Singh et al. | Medicinal Properties of Miracle Plant: Moringa oleifera |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |